HPV6L1 protein-resisting antibody, preparation method therefor and application thereof

The invention provides an antibody or an antigen bound part which is specifically bound to a human papilloma virus low-risk sub type-type 6 L1 protein and/or VLP. The antibody or the antigen bound part comprises CDR1, CDR2 and CDR3 regions of a heavy chain variable region shown in SEQ ID NO. 1-3 and...

Full description

Saved in:
Bibliographic Details
Main Authors CHEN SHI, DU LIFANG, GUO SHUYANG, MA ZHIJING, HAN ZIPO, LI QIMING, ZHANG JING
Format Patent
LanguageEnglish
Published 16.12.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention provides an antibody or an antigen bound part which is specifically bound to a human papilloma virus low-risk sub type-type 6 L1 protein and/or VLP. The antibody or the antigen bound part comprises CDR1, CDR2 and CDR3 regions of a heavy chain variable region shown in SEQ ID NO. 1-3 and CDR1, CDR2 and CDR3 regions of a light chain variable region shown in SEQ ID NO. 4-6. The antibody or the antigen bound part which is specifically bound with the human papilloma virus low-risk sub type-type 6 L1 protein and/or VLP has no cross reactions with most of other HPV sub types such as HPV11, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68 and the like, is high in specificity, has a characteristic of neutralizing a HPV6 pseudovirus and blocking infection of the pseudovirus, and is high in affinity. A twin-antibody sandwiched ELISA detection kit established by two antibodies can be used for detecting the presence or level of HPV6L1 protein and the antibody can be further used for treatment of patients and passive immunity of susceptible population and has a good application prospect.
AbstractList The invention provides an antibody or an antigen bound part which is specifically bound to a human papilloma virus low-risk sub type-type 6 L1 protein and/or VLP. The antibody or the antigen bound part comprises CDR1, CDR2 and CDR3 regions of a heavy chain variable region shown in SEQ ID NO. 1-3 and CDR1, CDR2 and CDR3 regions of a light chain variable region shown in SEQ ID NO. 4-6. The antibody or the antigen bound part which is specifically bound with the human papilloma virus low-risk sub type-type 6 L1 protein and/or VLP has no cross reactions with most of other HPV sub types such as HPV11, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68 and the like, is high in specificity, has a characteristic of neutralizing a HPV6 pseudovirus and blocking infection of the pseudovirus, and is high in affinity. A twin-antibody sandwiched ELISA detection kit established by two antibodies can be used for detecting the presence or level of HPV6L1 protein and the antibody can be further used for treatment of patients and passive immunity of susceptible population and has a good application prospect.
Author MA ZHIJING
HAN ZIPO
CHEN SHI
ZHANG JING
DU LIFANG
LI QIMING
GUO SHUYANG
Author_xml – fullname: CHEN SHI
– fullname: DU LIFANG
– fullname: GUO SHUYANG
– fullname: MA ZHIJING
– fullname: HAN ZIPO
– fullname: LI QIMING
– fullname: ZHANG JING
BookMark eNqNyr8KwjAQgPEMOvin7xB3C42l7lKUDiIO0rXE5mID9e5IbvHtLeoDOH3D71uqGRLCQrXNtd2fjeZIAgHzCCkkCfjQFiXcyb22kwHbaCUQ6ifIQE7LABE8xely2jKPof_6B8iv1dzbMUH260ptTsdb3eTA1EFi2wOCdPXFFJWpyrLYHcp_njdDejtJ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Physics
ExternalDocumentID CN105153302A
GroupedDBID EVB
ID FETCH-epo_espacenet_CN105153302A3
IEDL.DBID EVB
IngestDate Fri Jul 19 16:41:20 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN105153302A3
Notes Application Number: CN20151438587
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151216&DB=EPODOC&CC=CN&NR=105153302A
ParticipantIDs epo_espacenet_CN105153302A
PublicationCentury 2000
PublicationDate 20151216
PublicationDateYYYYMMDD 2015-12-16
PublicationDate_xml – month: 12
  year: 2015
  text: 20151216
  day: 16
PublicationDecade 2010
PublicationYear 2015
RelatedCompanies NATIONAL VACCINE & SERUM INSTITUTE CO., LTD
RelatedCompanies_xml – name: NATIONAL VACCINE & SERUM INSTITUTE CO., LTD
Score 3.0120335
Snippet The invention provides an antibody or an antigen bound part which is specifically bound to a human papilloma virus low-risk sub type-type 6 L1 protein and/or...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
TESTING
VINEGAR
WINE
Title HPV6L1 protein-resisting antibody, preparation method therefor and application thereof
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151216&DB=EPODOC&locale=&CC=CN&NR=105153302A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fT8IwEL4g_nxT1Cj-yEzMnlxksHXbw2KkgxAjYzFIeCO068x86IjMGP97rwWEF329a5r1ktt9X3v9CnCrIH7GmLBSFmSWkkC3Aua3LB-JWzb1vYzpPd1-THqvztPYHVfgfXUXRuuEfmlxRMwojvle6v_1bL2JFeneyvk9y9FUPHSHYWQu2bEqXzYxo3bYSQbRgJqUhjQ24xfEuq5CNo3m4xZsI4z2VDZ0Rm11K2W2WVK6h7CT4GyyPIKKkDXYp6uX12qw118eeNdgV3do8jkal1k4P4ZRLxmRZ9vQGgu5tJAxq0yVbwaGKWdF-n2HPrFQ9S6ksXgl2lBQTyBGxVGpsXFwvXAU2QncdDtD2rPwUye_cZnQeL2q1ilUZSHFGRheihZBkKfZ3OENBYC4T9LAmSoy5_JzqP89T_0_5wUcqBirbg6bXEK1_PgUV1iTS3atg_kDKAOQ2w
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fT8IwEL4g_sA3RY3ir5mYPbnIBMp4IEY6lqnbIAYX3gjdOjMfOiIzxv_eaxnCi77eNc16ye2-r71-BbiWED9hjBsx6ySGlEA3OsxqGBYSt2RqtROm9nT9gLivzadxa1yC9-VdGKUT-qXEETGjIsz3XP2vZ6tNLFv1Vs5vWYqm7N4ZdW29YMeyfJlEt3vd_nBgD6hOaZcGevCCWLclkU397mEDNhFit2U29MOevJUyWy8pzh5sDXE2ke9DiYsqVOjy5bUq7PjFgXcVtlWHZjRHY5GF8wMI3WFIPFNTGgupMJAxy0wVbxqGKWVZ_H2DPr5Q9c6EtnglWpNQjyNGxVGxtnZwvXBkySFcOf0RdQ381MlvXCY0WK2qcQRlkQl-DFo7RgsnyNPMqBnVJQCKLBJ3mlNJ5lrRCdT-nqf2n_MSKu7I9ybeY_B8Crsy3rKzwyRnUM4_Pvk51uecXajA_gAf25PO
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=HPV6L1+protein-resisting+antibody%2C+preparation+method+therefor+and+application+thereof&rft.inventor=CHEN+SHI&rft.inventor=DU+LIFANG&rft.inventor=GUO+SHUYANG&rft.inventor=MA+ZHIJING&rft.inventor=HAN+ZIPO&rft.inventor=LI+QIMING&rft.inventor=ZHANG+JING&rft.date=2015-12-16&rft.externalDBID=A&rft.externalDocID=CN105153302A